249 related articles for article (PubMed ID: 33827575)
1. The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.
Ascierto PA; Atkins MB; Eggermont AM; Gershenwald JE; Grob JJ; Hamid O; Sondak VK; Sosman JA; Tawbi HA; Weber JS; Caracò C; Osman I; Puzanov I
J Transl Med; 2021 Apr; 19(1):142. PubMed ID: 33827575
[TBL] [Abstract][Full Text] [Related]
2. The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.
Ascierto PA; Agarwala SS; Eggermont A; Gershenwald JE; Grob JJ; Hamid O; Michielin O; Postow M; Puzanov I; Zarour HM; Caracò C; Testori A
J Transl Med; 2020 Apr; 18(1):171. PubMed ID: 32299446
[TBL] [Abstract][Full Text] [Related]
3. The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
Ascierto PA; Warner AB; Blank C; Caracò C; Demaria S; Gershenwald JE; Khushalani NI; Long GV; Luke JJ; Mehnert JM; Robert C; Rutkowski P; Tawbi HA; Osman I; Puzanov I
J Transl Med; 2022 May; 20(1):200. PubMed ID: 35538491
[TBL] [Abstract][Full Text] [Related]
4. The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022.
Ascierto PA; Blank C; Eggermont AM; Garbe C; Gershenwald JE; Hamid O; Hauschild A; Luke JJ; Mehnert JM; Sosman JA; Tawbi HA; Mandalà M; Testori A; Caracò C; Osman I; Puzanov I
J Transl Med; 2023 Apr; 21(1):265. PubMed ID: 37072748
[TBL] [Abstract][Full Text] [Related]
5. The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018.
Ascierto PA; Bruzzi P; Eggermont A; Hamid O; Tawbi HA; van Akkooi A; Testori A; Caracò C; Puzanov I; Perrone F
J Transl Med; 2019 May; 17(1):148. PubMed ID: 31077205
[TBL] [Abstract][Full Text] [Related]
6. The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020.
Ascierto PA; Brody J; Butterfield LH; Finn OJ; Goldberg J; Perrone F; Sullivan RJ; Fox BA; Hwu P; Puzanov I
J Transl Med; 2021 Apr; 19(1):144. PubMed ID: 33827609
[TBL] [Abstract][Full Text] [Related]
7. The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.
Ascierto PA; Caracò C; Gershenwald JE; Hamid O; Ross M; Sullivan RJ; Puzanov I
J Transl Med; 2018 Apr; 16(1):101. PubMed ID: 29665799
[TBL] [Abstract][Full Text] [Related]
8. The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021.
Ascierto PA; Butterfield LH; Finn OJ; Futreal A; Hamid O; LaVallee T; Postow MA; Puzanov I; Sosman J; Fox BA; Hwu P
J Transl Med; 2022 Apr; 20(1):179. PubMed ID: 35449104
[TBL] [Abstract][Full Text] [Related]
9. The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.
Ascierto PA; Brentjens R; Khleif SN; Odunsi K; Rezvani K; Ruella M; Sullivan RJ; Fox BA; Puzanov I
J Transl Med; 2023 Apr; 21(1):275. PubMed ID: 37087493
[TBL] [Abstract][Full Text] [Related]
10. Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy).
Ascierto PA; Agarwala SS; Botti G; Budillon A; Davies MA; Dummer R; Ernstoff M; Ferrone S; Formenti S; Gajewski TF; Garbe C; Hamid O; Lo RS; Luke JJ; Michielin O; Palmieri G; Zitvogel L; Marincola FM; Masucci G; Caracò C; Thurin M; Puzanov I
J Transl Med; 2019 Jul; 17(1):234. PubMed ID: 31331337
[TBL] [Abstract][Full Text] [Related]
11. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
Ascierto PA; Blank C; Dummer R; Ernstoff MS; Ferrone S; Fox BA; Gajewski TF; Garbe C; Hwu P; Kalinski P; Krogsgaard M; Lo RS; Luke JJ; Neyns B; Postow MA; Quezada SA; Teng MWL; Trinchieri G; Testori A; Caracò C; Osman I; Puzanov I; Thurin M
J Transl Med; 2021 Jun; 19(1):278. PubMed ID: 34193182
[TBL] [Abstract][Full Text] [Related]
12. Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
Ascierto PA; Puzanov I; Agarwala SS; Blank C; Carvajal RD; Demaria S; Dummer R; Ernstoff M; Ferrone S; Fox BA; Gajewski TF; Garbe C; Hwu P; Lo RS; Long GV; Luke JJ; Osman I; Postow MA; Sullivan RJ; Taube JM; Trinchieri G; Zarour HM; Caracò C; Thurin M
J Transl Med; 2020 Sep; 18(1):346. PubMed ID: 32894202
[TBL] [Abstract][Full Text] [Related]
13. The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018.
Ascierto PA; Butterfield LH; Demaria S; Ferris RL; Freeman GJ; Lo RS; Mantovani A; Nathan P; Hamid O; Politi K; Puzanov I
J Immunother Cancer; 2019 Aug; 7(1):221. PubMed ID: 31416487
[TBL] [Abstract][Full Text] [Related]
14. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
Ascierto PA; Agarwala SS; Warner AB; Ernstoff MS; Fox BA; Gajewski TF; Galon J; Garbe C; Gastman BR; Gershenwald JE; Kalinski P; Krogsgaard M; Leidner RS; Lo RS; Menzies AM; Michielin O; Poulikakos PI; Weber JS; Caracò C; Osman I; Puzanov I; Thurin M
J Transl Med; 2023 Jul; 21(1):508. PubMed ID: 37507765
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant treatment for stage III and IV cutaneous melanoma.
Gorry C; McCullagh L; O'Donnell H; Barrett S; Schmitz S; Barry M; Curtin K; Beausang E; Barry R; Coyne I
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012974. PubMed ID: 36648215
[TBL] [Abstract][Full Text] [Related]
16. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
17. News from the melanoma sessions of the European Cancer Congress 2017.
Rutkowski P; Kozak K
BMC Med; 2017 Mar; 15(1):57. PubMed ID: 28302128
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach.
Davar D; Tarhini AA; Kirkwood JM
Clin Dermatol; 2013; 31(3):237-50. PubMed ID: 23608443
[TBL] [Abstract][Full Text] [Related]
20. (Neo)adjuvant systemic therapy for melanoma.
van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
